Novanta Inc. (NOVT) Stock

Novanta Inc. (NOVT) is a Industrials stock trading at $145.44 (as of 2026-08-20), with a market capitalization of $5.18B and a trailing P/E of 96.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Novanta Inc. designs, manufactures, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in medical and industrial markets. Its photonics offerings include laser and optical engine products; vision products include medical devices and imaging, operating-room visualization and recording technologies, data collection and machine vision; and precision motion provides encoders, motors, servo drives, and motion control.

Understand Novanta Inc.: how it makes money

Novanta designs and manufactures photonics, vision, and precision motion components and sub-systems, selling them to original equipment manufacturers (OEMs) in medical and industrial markets.

Revenue visibility and profit follow OEM order momentum, since the company reports overall Book-to-Bill Ratio above 1 (1.1) and very strong book-to-bill in key technology segments (Photonics 1.9, Vision 1.4, Precision Motion 1.43), while demand mix is split between medical (54% of sales) and advanced industrial (46%).

Revenue by segment (latest quarter)
Robotics & Aut.$0.1B
Precision Motion$0.1B
Vision$0.1B
Photonics$0.1B

Business quality (Mixed): Good read on near-term demand momentum (book-to-bill) and product freshness (vitality index), with some segment order weakness visible (sub-1 book-to-bill in certain groupings).

Valuation: At 113× earnings, NOVT trades 220% above the Electrical Equipment average (35×). Note: one-time items can distort reported P/E.

Bull case

  • Order momentum is positive overall: Overall Book-to-Bill Ratio is 1.1, indicating orders are slightly ahead of revenue timing.
  • Stronger demand in core technology: Segment Book-to-Bill Ratio is high in Photonics (1.9), Vision (1.4), and Precision Motion (1.43).
  • Product pipeline shows activity: Vitality Index (Revenue From New Products Launched in the Last Four Years) is 27.0%, and Vitality Index (Vision Segment) is 30.0%.

Bear case

  • Not all segments show strong order momentum: Book-to-Bill Ratio is below 1 for Automation Enabling Technologies (0.9) and for Precision Medicine and Manufacturing (0.73).
  • Possible customer and application concentration: Medical Markets Share of Sales is 54.0%, and Advanced Industrial Markets Share of Sales is 46.0%, so results depend on both areas continuing to spend.
  • Exposure to GenAI data center demand is material: GenAI Data Center Exposure (Percentage of Revenue) is 15.0%, which could become a headwind if data center-related demand weakens.
Valuation — source: SEC EDGAR (first-party)
Price$145.44
Market Cap$5.18B
P/E Ratio96.4
EV / EBITDA33.2
Price / Book3.95
Price / Sales5.15
FCF Yield1.3%
DCF Value (model)$19.09
DCF Upside vs Price-86.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$980.60M
Net Margin5.5%
Revenue Growth (YoY)10.4%
EPS Growth (YoY)-11.9%
FCF Growth (YoY)73.2%
Financial Health — source: SEC EDGAR
Altman Z-Score7.66 (safe)
Piotroski F-Score6/9 (moderate)
Valuation vs Sector & Industry
Stock P/E96.4
Sector P/E (Industrials)25.9
Industry P/E (Electrical Equipment)37.8
vs Sector272.4%
vs Industry155.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($549.79M)
Institutional Holders Tracked10
Congressional Trades (recent)5
Company
SectorIndustrials
IndustryElectrical Equipment
CEOMatthijs Glastra
Employees3,000
CountryUS
IPO Date1999-03-24

Related Companies (Business model: Industrials / Capital Goods (Heavy Machinery + Diversified Industrials); 8 closest by market cap; US-domiciled)

  • EnerSys (ENS)
  • QuantumScape Corporation (QS)
  • Atkore Inc. (ATKR)
  • Evolution Metals & Technologies Corp. Common Stock (EMAT)
  • Spectrum Brands Holdings, Inc. (SPB)
  • Fluence Energy, Inc. (FLNC)
  • Amprius Technologies, Inc. (AMPX)
  • Energizer Holdings, Inc. (ENR)
NOVT earnings history · NOVT institutional & insider holders · NOVT KPIs & operating metrics · NOVT financials · NOVT investor presentations & press releases · NOVT SEC filings · NOVT peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.